JFDA approves AstraZeneca vaccine for emergency use

Jordan

Published: 2021-02-09 19:58

Last Updated: 2021-09-26 09:00


JFDA approves AstraZeneca vaccine for emergency use
JFDA approves  AstraZeneca vaccine for emergency use

The Jordan Food and Drug Administration (JFDA) approved the COVID-19 AstraZeneca vaccine for emergency use. This makes AstraZeneca the third vaccine to get approved in the Kingdom after the Pfizer-BioNTech and Sinopharm vaccines.

Jordan began its national vaccination campaign, using the Pfizer-BioNTech and Sinopharm vaccines on Jan. 13. On Feb. 4, the Kingdom's health directorates began administering the second dose of the coronavirus vaccine in Jordan.


Also Read: Hayajneh announces groups excluded from COVID-19 vaccination in Jordan